Lotus Eye Hospital and Institute Limited

NSEI:LOTUSEYE 주식 보고서

시가총액: ₹1.3b

Lotus Eye Hospital and Institute 관리

관리 기준 확인 4/4

Lotus Eye Hospital and Institute CEO는 Kuttapalayam Ramalingam, Aug2020 에 임명되었습니다 의 임기는 4.25 년입니다. 는 ₹ 19.07M 가치에 해당하는 회사 주식의 1.43% 직접 소유합니다. 19.07M. 경영진과 이사회의 평균 재임 기간은 각각 4.2 년과 3.8 년입니다.

주요 정보

Kuttapalayam Ramalingam

최고 경영자

₹1.2m

총 보상

CEO 급여 비율n/a
CEO 임기4.3yrs
CEO 소유권1.4%
경영진 평균 재임 기간4.2yrs
이사회 평균 재임 기간3.8yrs

최근 관리 업데이트

Recent updates

Optimistic Investors Push Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) Shares Up 25% But Growth Is Lacking

Aug 21
Optimistic Investors Push Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) Shares Up 25% But Growth Is Lacking

Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) Price Is Out Of Tune With Earnings

Jan 24
Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) Price Is Out Of Tune With Earnings

Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50

Sep 08
Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50

We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease

Jul 15
We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease

Here's Why Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Has Caught The Eye Of Investors

Apr 07
Here's Why Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Has Caught The Eye Of Investors

We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease

Oct 08
We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease

Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50

Sep 02
Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50

If EPS Growth Is Important To You, Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Presents An Opportunity

Jun 17
If EPS Growth Is Important To You, Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Presents An Opportunity

MD & Whole Time Director Sangeetha Sundaramoorthy Just Bought 2.8% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

Mar 11
MD & Whole Time Director Sangeetha Sundaramoorthy Just Bought 2.8% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

Chief Executive Officer K. Ramalingam Just Bought 122% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

Dec 30
Chief Executive Officer K. Ramalingam Just Bought 122% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

Insider Buying: The Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) MD & Whole Time Director Just Bought 2.8% More Shares

Nov 20
Insider Buying: The Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) MD & Whole Time Director Just Bought 2.8% More Shares

The Chief Executive Officer of Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE), K. Ramalingam, Just Bought 17% More Shares

Sep 21
The Chief Executive Officer of Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE), K. Ramalingam, Just Bought 17% More Shares

Why Investors Shouldn't Be Surprised By Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) P/E

Aug 27
Why Investors Shouldn't Be Surprised By Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) P/E

Should You Take Comfort From Insider Transactions At Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)?

Aug 03
Should You Take Comfort From Insider Transactions At Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)?

Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) P/E Isn't Throwing Up Surprises

Jul 06
Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) P/E Isn't Throwing Up Surprises

CEO

Kuttapalayam Ramalingam (74 yo)

4.3yrs

테뉴어

₹1,200,000

보상

Dr. Kuttapalayam Songappan Ramalingam, M.D., serves as an Executive Director at Lotus Eye Hospital and Institute Limited since February 10, 2021. Dr. Ramalingam serves as Chief Executive Officer at Lotus E...


리더십 팀

이름위치테뉴어보상소유권
Kuttapalayam Ramalingam
CEO & Executive Director4.3yrs₹1.20m1.43%
₹ 19.1m
Ramanujam Reghunathan
Chief Financial Officer2.5yrs₹1.70m데이터 없음
Mohanmenon Menon
Company Secretary & Compliance Officer2.8yrs₹1.08m데이터 없음
Sangeetha Sundaramoorthy
MD & Director4.2yrs₹3.09m18.84%
₹ 250.4m
Rajkumar Sundaramoorthy
Vice President of Administration6.5yrs데이터 없음0%
₹ 0

4.2yrs

평균 재임 기간

67yo

평균 연령

경험이 풍부한 관리: LOTUSEYE 의 관리팀은 경험 ( 4.2 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Kuttapalayam Ramalingam
CEO & Executive Director3.8yrs₹1.20m1.43%
₹ 19.1m
Sangeetha Sundaramoorthy
MD & Director5yrs₹3.09m18.84%
₹ 250.4m
Rajkumar Sundaramoorthy
Vice President of Administration4.8yrs데이터 없음0%
₹ 0
Kavetha Sundaramoorthy
Chairman of the Board8.5yrs₹150.00k18.78%
₹ 249.6m
Sengodagounder Natesan
Independent Director3.8yrs₹200.00k데이터 없음
Gopalakrishnan Veeramani
Independent Non-Executive Director1.9yrs₹200.00k데이터 없음
Perumalsamy Mahendran
Independent Non-Executive Director1.8yrs₹175.00k데이터 없음

3.8yrs

평균 재임 기간

61yo

평균 연령

경험이 풍부한 이사회: LOTUSEYE 의 이사회경험(평균 재직 기간 3.8 년)으로 간주됩니다.